IL17A and chronic rhinosinusitis: Primary human nasal epithelial cells taken from chronic rhinosinusitis with nasal polyp patients showed that the Th17 cytokines IL-17, IL-22, and IL-26 enhanced the significant disruption of the epithelial barrier, evidenced by a loss of transepithelial electrical resistance and increased paracellular permeability [102].